Surface Ophthalmics
About:
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases.
Website: https://surfaceophthalmics.com
Description:
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases. The company's current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity, a patented delivery vehicle. Surface Ophthalmics was founded in 2017 and is based in Pleasanton, California.
Total Funding Amount:
$40M
Headquarters Location:
Pleasanton, California, United States
Founded Date:
2016-01-01
Founders:
Kamran Hosseini, Mark Baum
Number of Employees:
1-10
Last Funding Date:
2021-06-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai